BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 3587902)

  • 1. Localized orbital rhabdomyosarcoma. An interim report of the Intergroup Rhabdomyosarcoma Study Committee.
    Wharam M; Beltangady M; Hays D; Heyn R; Ragab A; Soule E; Tefft M; Maurer H
    Ophthalmology; 1987 Mar; 94(3):251-4. PubMed ID: 3587902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
    Crist WM; Anderson JR; Meza JL; Fryer C; Raney RB; Ruymann FB; Breneman J; Qualman SJ; Wiener E; Wharam M; Lobe T; Webber B; Maurer HM; Donaldson SS
    J Clin Oncol; 2001 Jun; 19(12):3091-102. PubMed ID: 11408506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary ophthalmic rhabdomyosarcoma in 33 patients.
    Shields CL; Shields JA; Honavar SG; Demirci H
    Trans Am Ophthalmol Soc; 2001; 99():133-42; discussion 142-3. PubMed ID: 11797301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orbital rhabdomyosarcomas and related tumors in childhood: relationship of morphology to prognosis--an Intergroup Rhabdomyosarcoma study.
    Kodet R; Newton WA; Hamoudi AB; Asmar L; Wharam MD; Maurer HM
    Med Pediatr Oncol; 1997 Jul; 29(1):51-60. PubMed ID: 9142207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.
    Wharam MD; Meza J; Anderson J; Breneman JC; Donaldson SS; Fitzgerald TJ; Michalski J; Teot LA; Wiener ES; Meyer WH
    J Clin Oncol; 2004 May; 22(10):1902-8. PubMed ID: 15143083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical spectrum of primary ophthalmic rhabdomyosarcoma.
    Shields CL; Shields JA; Honavar SG; Demirci H
    Ophthalmology; 2001 Dec; 108(12):2284-92. PubMed ID: 11733272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local Resection and Brachytherapy for Primary Orbital Rhabdomyosarcoma: Outcome and Failure Pattern Analysis.
    Schoot RA; Saeed P; Freling NJ; Blank LE; Pieters BR; van der Grient JN; Strackee SD; Bras J; Caron HN; Merks JH;
    Ophthalmic Plast Reconstr Surg; 2016; 32(5):354-60. PubMed ID: 26398242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary treatment of primary orbital rhabdomyosarcoma. A single-institution experience.
    Fiorillo A; Migliorati R; Grimaldi M; Vassallo P; Canale G; Tranfa F; Uccello G; Fiore M; Muto P; Menna G
    Cancer; 1991 Feb; 67(3):560-3. PubMed ID: 1985749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of orbital rhabdomyosarcoma in children in Japan.
    Takahashi N; Minoda K
    Jpn J Ophthalmol; 1991; 35(3):292-9. PubMed ID: 1770669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary collaborative therapy for 30 children with orbital rhabdomyosarcoma.
    Ge X; Huang DS; Shi JT; Ma JM
    Asian Pac J Cancer Prev; 2013; 14(8):4641-6. PubMed ID: 24083717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the results of treatment orbital rhabdomyosarcoma in children].
    Chipczyńska B; Grałek M; Hautz W; Kanigowska K; Kocyła-Karczmarewicz B; Trzebicka A; Kepa B
    Klin Oczna; 2007; 109(1-3):18-21. PubMed ID: 17687906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology Group.
    Raney B; Huh W; Hawkins D; Hayes-Jordan A; Million L; Rodeberg D; Teot L; Anderson J;
    Pediatr Blood Cancer; 2013 Mar; 60(3):371-6. PubMed ID: 22961750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term evaluation of orbital rhabdomyosarcoma in children.
    Boutroux H; Levy C; Mosseri V; Desjardins L; Plancher C; Helfre S; Freneaux P; Cellier C; Orbach D
    Clin Exp Ophthalmol; 2015; 43(1):12-9. PubMed ID: 24923774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rhabdomyosarcoma of the orbits in childhood].
    Humpl T; Brühl K; Pitz S; de Mooy P; Bartels U; Gutjahr P
    Ophthalmologe; 1997 Dec; 94(12):914-9. PubMed ID: 9487763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-line therapy in young patients with relapsed or refractory orbital rhabdomyosarcoma.
    Zloto O; Minard-Colin V; Boutroux H; Brisse HJ; Levy C; Kolb F; Bolle S; Carton M; Helfre S; Orbach D
    Acta Ophthalmol; 2021 May; 99(3):334-341. PubMed ID: 32833335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late recurrence in orbital rhabdomyosarcoma: complete remission after multimodality management.
    Warrier AR; Syriac S; Rathnam KK
    J Cancer Res Ther; 2010; 6(3):307-9. PubMed ID: 21119259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthalmic complications following treatment of paranasal sinus rhabdomyosarcoma in comparison to orbital disease.
    Gandhi PD; Fleming JC; Haik BG; Wilson MW
    Ophthalmic Plast Reconstr Surg; 2011; 27(4):241-6. PubMed ID: 21242849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Update of orbital rhabdomyosarcoma therapy in children].
    Ducrey N; Nenadov-Beck M; Spahn B
    J Fr Ophtalmol; 2002 Mar; 25(3):298-302. PubMed ID: 11941256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhabdomyosarcoma: the Stanford experience using a TNM staging system.
    Pedrick TJ; Donaldson SS; Cox RS
    J Clin Oncol; 1986 Mar; 4(3):370-8. PubMed ID: 3950676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL; Anderson J; Pappo AS; Meyer WH;
    J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.